アクティブ埋め込み型デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global Active Implantable Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-00115 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、107ページ • 納品方法：Eメール • 産業分類：医療機器・医療消耗品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、アクティブ埋め込み型デバイスの世界市場を広く調査・分析し、今後の市場展望をまとめております。アクティブ埋め込み型デバイスの種類別市場規模（埋め込み型除細動器、埋め込み型心臓ペースメーカー、心室補助装置、埋め込み型心臓モニター/挿入型ループレコーダー、神経刺激装置、埋め込み型聴覚装置）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：LivaNova PLC (U.K.)、Nurotron Biotechnology (China)、Abbott Laboratories (U.S.)、MED-EL (Austria)、Cochlear Limited (Australia)、Medtronic (Ireland)、William Demant Holding (Denmark)、Boston Scientific Corporation (U.S.)、BIOTRONIK (Germany)、Sonova Holding Switzerland) ・地域別グローバル市場分析 2015年-2020年 ・アクティブ埋め込み型デバイスの北米市場（アメリカ、カナダ、メキシコ） ・アクティブ埋め込み型デバイスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・アクティブ埋め込み型デバイスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・アクティブ埋め込み型デバイスの南米市場（ブラジル、アルゼンチン） ・アクティブ埋め込み型デバイスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：埋め込み型除細動器、埋め込み型心臓ペースメーカー、心室補助装置、埋め込み型心臓モニター/挿入型ループレコーダー、神経刺激装置、埋め込み型聴覚装置 ・用途別分析：病院、クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Active Implantable Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Active Implantable Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Active Implantable Devices market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Active Implantable Devices market has been segmented into
Implantable Cardioverter Defibrillator
Implantable Cardiac Pacemakers
Ventricular Assist Devices
Implantable Heart Monitors/Insertable Loop Recorders
Neurostimulators
Implantable Hearing Devices

By Application, Active Implantable Devices has been segmented into:
Hospital
Clinic

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Active Implantable Devices market presented in the report. This section sheds light on the sales growth of different regional and country-level Active Implantable Devices markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Active Implantable Devices market.

The report offers in-depth assessment of the growth and other aspects of the Active Implantable Devices market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Active Implantable Devices Market Share Analysis
Active Implantable Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Active Implantable Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Active Implantable Devices sales, revenue and market share for each player covered in this report.

The major players covered in Active Implantable Devices are:
LivaNova PLC (U.K.)
Nurotron Biotechnology (China)
Abbott Laboratories (U.S.)
MED-EL (Austria)
Cochlear Limited (Australia)
Medtronic (Ireland)
William Demant Holding (Denmark)
Boston Scientific Corporation (U.S.)
BIOTRONIK (Germany)
Sonova Holding Switzerland)

Among other players domestic and global, Active Implantable Devices market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Active Implantable Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Active Implantable Devices, with price, sales, revenue and global market share of Active Implantable Devices in 2018 and 2019.
Chapter 3, the Active Implantable Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Active Implantable Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Active Implantable Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Active Implantable Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Active Implantable Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Active Implantable Devices Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Implantable Cardioverter Defibrillator
1.2.3 Implantable Cardiac Pacemakers
1.2.4 Ventricular Assist Devices
1.2.5 Implantable Heart Monitors/Insertable Loop Recorders
1.2.6 Neurostimulators
1.2.7 Implantable Hearing Devices
1.3 Market Analysis by Application
1.3.1 Overview: Global Active Implantable Devices Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.4 Overview of Global Active Implantable Devices Market
1.4.1 Global Active Implantable Devices Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 LivaNova PLC (U.K.)
2.1.1 LivaNova PLC (U.K.) Details
2.1.2 LivaNova PLC (U.K.) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 LivaNova PLC (U.K.) SWOT Analysis
2.1.4 LivaNova PLC (U.K.) Product and Services
2.1.5 LivaNova PLC (U.K.) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Nurotron Biotechnology (China)
2.2.1 Nurotron Biotechnology (China) Details
2.2.2 Nurotron Biotechnology (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Nurotron Biotechnology (China) SWOT Analysis
2.2.4 Nurotron Biotechnology (China) Product and Services
2.2.5 Nurotron Biotechnology (China) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott Laboratories (U.S.)
2.3.1 Abbott Laboratories (U.S.) Details
2.3.2 Abbott Laboratories (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott Laboratories (U.S.) SWOT Analysis
2.3.4 Abbott Laboratories (U.S.) Product and Services
2.3.5 Abbott Laboratories (U.S.) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 MED-EL (Austria)
2.4.1 MED-EL (Austria) Details
2.4.2 MED-EL (Austria) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 MED-EL (Austria) SWOT Analysis
2.4.4 MED-EL (Austria) Product and Services
2.4.5 MED-EL (Austria) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cochlear Limited (Australia)
2.5.1 Cochlear Limited (Australia) Details
2.5.2 Cochlear Limited (Australia) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cochlear Limited (Australia) SWOT Analysis
2.5.4 Cochlear Limited (Australia) Product and Services
2.5.5 Cochlear Limited (Australia) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Medtronic (Ireland)
2.6.1 Medtronic (Ireland) Details
2.6.2 Medtronic (Ireland) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Medtronic (Ireland) SWOT Analysis
2.6.4 Medtronic (Ireland) Product and Services
2.6.5 Medtronic (Ireland) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 William Demant Holding (Denmark)
2.7.1 William Demant Holding (Denmark) Details
2.7.2 William Demant Holding (Denmark) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 William Demant Holding (Denmark) SWOT Analysis
2.7.4 William Demant Holding (Denmark) Product and Services
2.7.5 William Demant Holding (Denmark) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Boston Scientific Corporation (U.S.)
2.8.1 Boston Scientific Corporation (U.S.) Details
2.8.2 Boston Scientific Corporation (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Boston Scientific Corporation (U.S.) SWOT Analysis
2.8.4 Boston Scientific Corporation (U.S.) Product and Services
2.8.5 Boston Scientific Corporation (U.S.) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 BIOTRONIK (Germany)
2.9.1 BIOTRONIK (Germany) Details
2.9.2 BIOTRONIK (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BIOTRONIK (Germany) SWOT Analysis
2.9.4 BIOTRONIK (Germany) Product and Services
2.9.5 BIOTRONIK (Germany) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sonova Holding Switzerland)
2.10.1 Sonova Holding Switzerland) Details
2.10.2 Sonova Holding Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sonova Holding Switzerland) SWOT Analysis
2.10.4 Sonova Holding Switzerland) Product and Services
2.10.5 Sonova Holding Switzerland) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Active Implantable Devices Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Active Implantable Devices Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Active Implantable Devices Manufacturer Market Share in 2019
3.3.2 Top 6 Active Implantable Devices Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Active Implantable Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Active Implantable Devices Sales and Market Share by Regions (2015-2020)
4.1.2 Global Active Implantable Devices Revenue and Market Share by Regions (2015-2020)
4.2 North America Active Implantable Devices Sales and Growth Rate (2015-2020)
4.3 Europe Active Implantable Devices Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Active Implantable Devices Sales and Growth Rate (2015-2020)
4.5 South America Active Implantable Devices Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Active Implantable Devices Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Active Implantable Devices Sales, Revenue and Market Share by Country
5.1.1 North America Active Implantable Devices Sales and Market Share by Country (2015-2020)
5.1.2 North America Active Implantable Devices Revenue and Market Share by Country (2015-2020)
5.2 United States Active Implantable Devices Sales and Growth Rate (2015-2020)
5.3 Canada Active Implantable Devices Sales and Growth Rate (2015-2020)
5.4 Mexico Active Implantable Devices Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Active Implantable Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Active Implantable Devices Sales and Market Share by Country (2015-2020)
6.1.2 Europe Active Implantable Devices Revenue and Market Share by Country (2015-2020)
6.2 Germany Active Implantable Devices Sales and Growth Rate (2015-2020)
6.3 UK Active Implantable Devices Sales and Growth Rate (2015-2020)
6.4 France Active Implantable Devices Sales and Growth Rate (2015-2020)
6.5 Russia Active Implantable Devices Sales and Growth Rate (2015-2020)
6.6 Italy Active Implantable Devices Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Active Implantable Devices Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Active Implantable Devices Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Active Implantable Devices Revenue and Market Share by Regions (2015-2020)
7.2 China Active Implantable Devices Sales and Growth Rate (2015-2020)
7.3 Japan Active Implantable Devices Sales and Growth Rate (2015-2020)
7.4 Korea Active Implantable Devices Sales and Growth Rate (2015-2020)
7.5 India Active Implantable Devices Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Active Implantable Devices Sales and Growth Rate (2015-2020)
7.7 Australia Active Implantable Devices Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Active Implantable Devices Sales, Revenue and Market Share by Country
8.1.1 South America Active Implantable Devices Sales and Market Share by Country (2015-2020)
8.1.2 South America Active Implantable Devices Revenue and Market Share by Country (2015-2020)
8.2 Brazil Active Implantable Devices Sales and Growth Rate (2015-2020)
8.3 Argentina Active Implantable Devices Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Active Implantable Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Active Implantable Devices Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Active Implantable Devices Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Active Implantable Devices Sales and Growth Rate (2015-2020)
9.3 Turkey Active Implantable Devices Sales and Growth Rate (2015-2020)
9.4 Egypt Active Implantable Devices Sales and Growth Rate (2015-2020)
9.5 South Africa Active Implantable Devices Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Active Implantable Devices Sales and Market Share by Type (2015-2020)
10.2 Global Active Implantable Devices Revenue and Market Share by Type (2015-2020)
10.3 Global Active Implantable Devices Price by Type (2015-2020)
11 Global Active Implantable Devices Market Segment by Application
11.1 Global Active Implantable Devices Sales Market Share by Application (2015-2020)
11.2 Global Active Implantable Devices Revenue Market Share by Application (2015-2020)
11.3 Global Active Implantable Devices Price by Application (2015-2020)
12 Market Forecast
12.1 Global Active Implantable Devices Sales, Revenue and Growth Rate (2021-2025)
12.2 Active Implantable Devices Market Forecast by Regions (2021-2025)
12.2.1 North America Active Implantable Devices Market Forecast (2021-2025)
12.2.2 Europe Active Implantable Devices Market Forecast (2021-2025)
12.2.3 Asia-Pacific Active Implantable Devices Market Forecast (2021-2025)
12.2.4 South America Active Implantable Devices Market Forecast (2021-2025)
12.2.5 Middle East & Africa Active Implantable Devices Market Forecast (2021-2025)
12.3 Active Implantable Devices Market Forecast by Type (2021-2025)
12.3.1 Global Active Implantable Devices Sales Forecast by Type (2021-2025)
12.3.2 Global Active Implantable Devices Market Share Forecast by Type (2021-2025)
12.4 Active Implantable Devices Market Forecast by Application (2021-2025)
12.4.1 Global Active Implantable Devices Sales Forecast by Application (2021-2025)
12.4.2 Global Active Implantable Devices Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Active Implantable Devices Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Active Implantable Devices by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Active Implantable Devices Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. LivaNova PLC (U.K.) Basic Information, Manufacturing Base and Competitors
Table 8. LivaNova PLC (U.K.) Active Implantable Devices Major Business
Table 9. LivaNova PLC (U.K.) Active Implantable Devices Total Revenue (USD Million) (2018-2019)
Table 10. LivaNova PLC (U.K.) SWOT Analysis
Table 11. LivaNova PLC (U.K.) Active Implantable Devices Product and Services
Table 12. LivaNova PLC (U.K.) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Nurotron Biotechnology (China) Basic Information, Manufacturing Base and Competitors
Table 14. Nurotron Biotechnology (China) Active Implantable Devices Major Business
Table 15. Nurotron Biotechnology (China) Active Implantable Devices Total Revenue (USD Million) (2018-2019)
Table 16. Nurotron Biotechnology (China) SWOT Analysis
Table 17. Nurotron Biotechnology (China) Active Implantable Devices Product and Services
Table 18. Nurotron Biotechnology (China) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Abbott Laboratories (U.S.) Basic Information, Manufacturing Base and Competitors
Table 20. Abbott Laboratories (U.S.) Active Implantable Devices Major Business
Table 21. Abbott Laboratories (U.S.) Active Implantable Devices Total Revenue (USD Million) (2018-2019)
Table 22. Abbott Laboratories (U.S.) SWOT Analysis
Table 23. Abbott Laboratories (U.S.) Active Implantable Devices Product and Services
Table 24. Abbott Laboratories (U.S.) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. MED-EL (Austria) Basic Information, Manufacturing Base and Competitors
Table 26. MED-EL (Austria) Active Implantable Devices Major Business
Table 27. MED-EL (Austria) Active Implantable Devices Total Revenue (USD Million) (2018-2019)
Table 28. MED-EL (Austria) SWOT Analysis
Table 29. MED-EL (Austria) Active Implantable Devices Product and Services
Table 30. MED-EL (Austria) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Cochlear Limited (Australia) Basic Information, Manufacturing Base and Competitors
Table 32. Cochlear Limited (Australia) Active Implantable Devices Major Business
Table 33. Cochlear Limited (Australia) Active Implantable Devices Total Revenue (USD Million) (2018-2019)
Table 34. Cochlear Limited (Australia) SWOT Analysis
Table 35. Cochlear Limited (Australia) Active Implantable Devices Product and Services
Table 36. Cochlear Limited (Australia) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Medtronic (Ireland) Basic Information, Manufacturing Base and Competitors
Table 38. Medtronic (Ireland) Active Implantable Devices Major Business
Table 39. Medtronic (Ireland) Active Implantable Devices Total Revenue (USD Million) (2018-2019)
Table 40. Medtronic (Ireland) SWOT Analysis
Table 41. Medtronic (Ireland) Active Implantable Devices Product and Services
Table 42. Medtronic (Ireland) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. William Demant Holding (Denmark) Basic Information, Manufacturing Base and Competitors
Table 44. William Demant Holding (Denmark) Active Implantable Devices Major Business
Table 45. William Demant Holding (Denmark) Active Implantable Devices Total Revenue (USD Million) (2018-2019)
Table 46. William Demant Holding (Denmark) SWOT Analysis
Table 47. William Demant Holding (Denmark) Active Implantable Devices Product and Services
Table 48. William Demant Holding (Denmark) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Boston Scientific Corporation (U.S.) Basic Information, Manufacturing Base and Competitors
Table 50. Boston Scientific Corporation (U.S.) Active Implantable Devices Major Business
Table 51. Boston Scientific Corporation (U.S.) Active Implantable Devices Total Revenue (USD Million) (2018-2019)
Table 52. Boston Scientific Corporation (U.S.) SWOT Analysis
Table 53. Boston Scientific Corporation (U.S.) Active Implantable Devices Product and Services
Table 54. Boston Scientific Corporation (U.S.) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. BIOTRONIK (Germany) Basic Information, Manufacturing Base and Competitors
Table 56. BIOTRONIK (Germany) Active Implantable Devices Major Business
Table 57. BIOTRONIK (Germany) Active Implantable Devices Total Revenue (USD Million) (2018-2019)
Table 58. BIOTRONIK (Germany) SWOT Analysis
Table 59. BIOTRONIK (Germany) Active Implantable Devices Product and Services
Table 60. BIOTRONIK (Germany) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Sonova Holding Switzerland) Basic Information, Manufacturing Base and Competitors
Table 62. Sonova Holding Switzerland) Active Implantable Devices Major Business
Table 63. Sonova Holding Switzerland) Active Implantable Devices Total Revenue (USD Million) (2018-2019)
Table 64. Sonova Holding Switzerland) SWOT Analysis
Table 65. Sonova Holding Switzerland) Active Implantable Devices Product and Services
Table 66. Sonova Holding Switzerland) Active Implantable Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Active Implantable Devices Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Active Implantable Devices Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Active Implantable Devices Sales by Regions (2015-2020) (K Units)
Table 70. Global Active Implantable Devices Sales Market Share by Regions (2015-2020)
Table 71. Global Active Implantable Devices Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Active Implantable Devices Sales by Countries (2015-2020) (K Units)
Table 73. North America Active Implantable Devices Sales Market Share by Countries (2015-2020)
Table 74. North America Active Implantable Devices Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Active Implantable Devices Revenue Market Share by Countries (2015-2020)
Table 76. Europe Active Implantable Devices Sales by Countries (2015-2020) (K Units)
Table 77. Europe Active Implantable Devices Sales Market Share by Countries (2015-2020)
Table 78. Europe Active Implantable Devices Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Active Implantable Devices Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Active Implantable Devices Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Active Implantable Devices Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Active Implantable Devices Sales by Countries (2015-2020) (K Units)
Table 83. South America Active Implantable Devices Sales Market Share by Countries (2015-2020)
Table 84. South America Active Implantable Devices Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Active Implantable Devices Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Active Implantable Devices Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Active Implantable Devices Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Active Implantable Devices Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Active Implantable Devices Revenue Market Share by Countries (2015-2020)
Table 90. Global Active Implantable Devices Sales by Type (2015-2020) (K Units)
Table 91. Global Active Implantable Devices Sales Share by Type (2015-2020)
Table 92. Global Active Implantable Devices Revenue by Type (2015-2020) (USD Million)
Table 93. Global Active Implantable Devices Revenue Share by Type (2015-2020)
Table 94. Global Active Implantable Devices Sales by Application (2015-2020) (K Units)
Table 95. Global Active Implantable Devices Sales Share by Application (2015-2020)
Table 96. Global Active Implantable Devices Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Active Implantable Devices Market Share Forecast by Regions (2021-2025)
Table 98. Global Active Implantable Devices Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Active Implantable Devices Market Share Forecast by Type (2021-2025)
Table 100. Global Active Implantable Devices Sales Forecast by Application (2021-2025)
Table 101. Global Active Implantable Devices Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Active Implantable Devices Picture
Figure 2. Global Sales Market Share of Active Implantable Devices by Type in 2019
Figure 3. Implantable Cardioverter Defibrillator Picture
Figure 4. Implantable Cardiac Pacemakers Picture
Figure 5. Ventricular Assist Devices Picture
Figure 6. Implantable Heart Monitors/Insertable Loop Recorders Picture
Figure 7. Neurostimulators Picture
Figure 8. Implantable Hearing Devices Picture
Figure 9. Active Implantable Devices Sales Market Share by Application in 2018
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Global Active Implantable Devices Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Active Implantable Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Active Implantable Devices Sales Market Share by Manufacturer in 2019
Figure 33. Global Active Implantable Devices Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Active Implantable Devices Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Active Implantable Devices Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Active Implantable Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Active Implantable Devices Revenue Market Share by Regions (2015-2020)
Figure 40. Global Active Implantable Devices Revenue Market Share by Regions in 2018
Figure 41. North America Active Implantable Devices Sales and Growth Rate (2015-2020)
Figure 42. Europe Active Implantable Devices Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Active Implantable Devices Sales and Growth Rate (2015-2020)
Figure 44. South America Active Implantable Devices Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Active Implantable Devices Sales and Growth Rate (2015-2020)
Figure 46. North America Active Implantable Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Active Implantable Devices Sales Market Share by Countries (2015-2020)
Figure 48. North America Active Implantable Devices Sales Market Share by Countries in 2018
Figure 49. North America Active Implantable Devices Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Active Implantable Devices Revenue Market Share by Countries in 2018
Figure 51. United States Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Active Implantable Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Active Implantable Devices Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Active Implantable Devices Revenue Market Share by Countries in 2019
Figure 57. Germany Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Active Implantable Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Active Implantable Devices Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Active Implantable Devices Revenue Market Share by Regions 2019
Figure 65. China Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Active Implantable Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Active Implantable Devices Sales Market Share by Countries in 2019
Figure 72. South America Active Implantable Devices Revenue Market Share by Countries in 2019
Figure 73. Brazil Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Active Implantable Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Active Implantable Devices Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Active Implantable Devices Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Active Implantable Devices Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Active Implantable Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Active Implantable Devices Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Active Implantable Devices Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Active Implantable Devices Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Active Implantable Devices Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Active Implantable Devices Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Active Implantable Devices Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Active Implantable Devices Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel

---